ProStrakan Group plc is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major markets.

ProStrakan is a subsidiary of Kyowa Hakko Kirin Co. Ltd., the Japan-based global specialty pharmaceutical company.


Latest News


Prostrakan completes acquisition of Archimedes
06 August 2014
Download this Press Release »


Prostrakan Agreement to Acquire Archimedes
11 July 2014
Download this Press Release »

Our Products

ProStrakan markets a range of products in a number of key EU territories and the US.

Find out more ›



ProStrakan has a reputation for developing and bringing to market a number of high value products.

Find out more ›



At ProStrakan we want dynamic and innovative people. We want the best people, to develop their careers with us and to contribute to and share in our success. In return, we offer the chance to work in one of the world’s fastest-growing pharmaceutical companies, where innovation, dedication and application result in a rewarding and satisfying career.

For full details of all our current vacancies and opportunities for pharmaceutical professionals visit the Careers section of this website.